WO2003103624A1 - Method and composition for improving sensory characteristics of semisolid predominantly anhydrous - Google Patents

Method and composition for improving sensory characteristics of semisolid predominantly anhydrous Download PDF

Info

Publication number
WO2003103624A1
WO2003103624A1 PCT/IB2003/001700 IB0301700W WO03103624A1 WO 2003103624 A1 WO2003103624 A1 WO 2003103624A1 IB 0301700 W IB0301700 W IB 0301700W WO 03103624 A1 WO03103624 A1 WO 03103624A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
amphiphobic
particles
halocarbon
lipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2003/001700
Other languages
French (fr)
Other versions
WO2003103624B1 (en
Inventor
Hans R. Suess
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2004510744A priority Critical patent/JP2005533044A/en
Priority to CA002487961A priority patent/CA2487961A1/en
Priority to AU2003219445A priority patent/AU2003219445A1/en
Priority to EP03715257A priority patent/EP1519707A1/en
Publication of WO2003103624A1 publication Critical patent/WO2003103624A1/en
Publication of WO2003103624B1 publication Critical patent/WO2003103624B1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A61K8/70Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine containing perfluoro groups, e.g. perfluoroethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8123Compositions of homopolymers or copolymers of compounds having one carbon-to-carbon double bond, and at least one being terminated by a halogen; Compositions of derivatives of such polymers, e.g. PVC, PTFE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/004Aftersun preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30Characterized by the absence of a particular group of ingredients
    • A61K2800/31Anhydrous

Definitions

  • the present invention is directed to a method of improving the adhesion of semisolid predominantly anhydrous lipids to certain substrates. This method decreases oiliness, greasiness, stickiness, and tackiness and improves the adhesion of the lipids to a substrate.
  • These lipids may be applied to surfaces, including, but not limited to hair, leather, paper, skins textiles and wood, where an impermeableness against water, but not water vapor, is desirable.
  • the principal function of the skin is to keep water in and exogenous substances out. This is accomplished by a highly ordered barrier, located in the stratum corneum, the skin's outermost layer.
  • the stratum corneum composed of comeocytes (or horny cells) embedded in lipid lamellae, composed mainly of ceramides, cholesterol and free fatty acids.
  • the horny layer is incessantly exposed to an oxidative environment (including, but not limited to UN radiation, ozone, aerobic microorganisms, and metallic microparticles).
  • the homy layer is defended by antioxidant tocopherols, which are contained in the sebum that is continually secreted by the sebaceous glands, and ascorbic acid, which is secreted by the eccrine glands.
  • Anhydrous lipid-rich preparations such as petrolatum or lanolin, which are not easily washed-off, seem appealing but they are not used since they are lacking in cosmetic elegance. Therefore, less greasy skin creams are often applied.
  • Such skin creams are often emulsions containing emulsifiers which are known to be potential skin irritants. Additionally, such emulsions contain a water phase which has to be preserved in order to avoid microbial contamination. Perfumes are often included in these formulations. Both the preservatives and perfumes frequently cause allergic reactions. In the formulation of dermatological vehicles, therapeutic efficacy is an important goal. Skin penetration of active ingredients are frequently more enhanced by anhydrous semisolid excipients than by creams (which are semisolid emulsions). Anhydrous semi-solid excipients based on hydrocarbons moisturize the skin by occlusion and enhance overall skin quality more readily than creams.
  • anhydrous semi-solid hydrocarbon excipients do not degrade from bacterial lipases.
  • creams are very often preferred to ointments, in the art, because they are more pleasant to use and therefor better accepted by patients.
  • An amphiphilic product includes both hydrophilic and lipophilic groups.
  • An amphiphobic product does not include either a hydrophilic or a lipophilic group.
  • the greasier and stickier a moisturizer is, the less cosmetically acceptable it is. Increases in the lipid content of a moisturizer often increases the greasiness and stickiness of the moisturizer. For this reason, it is desirable to suppress the greasiness and stickiness of lipid-rich preparations (e.g. petrolatum or other formulations consisting mainly of hydrocarbons). As was recognized by Kligman twenty years ago, "A boon to all sufferers from dry skin would be a product with the efficacy of petrolatum and the hedonic-aesthetic properties of a light oil in water cream.” ( Kligman A.M.
  • Water is the plasticiser of the skin. Lipid content is of major importance to the plasticity of the skin because the presence of lipids decreases transepidermal water loss and consequently increases moisture content of the stratum corneum. Therefore, lipid-rich formulations are effective in the treatment of dry skin.
  • the present invention is quite unexpected.
  • the sensory characteristics, the aesthetic appeal and thereby the user acceptance of anhydrous semisolid lipids can be greatly improved with the addition of a combination of amphiphobic micro or sub-micro particles of polymerized perhalogenoalkenes and at least one amphiphilic lipid containing at least two hydroxyl groups.
  • semisolid lipids are mainly complex mixtures of hydrocarbons (e.g., without limitation, petrolatum) or combinations of liquid hydrocarbons (e.g., without limitation, paraffin oils or oligomers of monoolefins, e.g., without limitation, ethylene, propylene, butylene, isobutylene, and decene) with solid polymers of monoolefins, esters and combinations of liquid and /or solid esters
  • waxes e.g., without limitation, waxes
  • semisoft triglycerides or any combination thereof e.g., without limitation, lanolin or wool wax.
  • a preferred embodiment is anhydrous lanolin, a water-free refined substance, which is a rather complex mixture of esters of alcohols (e.g., without limitation, monohydric, dihydric, sterols, and friterpenols) with straight or branched fatty acids.
  • esters of alcohols e.g., without limitation, monohydric, dihydric, sterols, and friterpenols
  • the lipids, used in this invention preferably contain minimal quantities of water.
  • the amount depends on the chemical composition.
  • cenfrifuged raw wool wax contains 1-5 % water. At 32°C (the approximate temperature of the skin surface), water is only very slightly soluble in liquid hydrocarbons (less than
  • esters e.g., without limitation, dibutyladipat
  • esters may contain up to 100 times more water.
  • Lipids with high water content are less occlusive than lipids with low water content.
  • hydrocarbons which have a low water content, excel in the treatment of dry skin by occlusion.
  • Branched lipids e.g., without limitation, petrolatum
  • bulky lipids e.g., without limitation, anhydrous lanolin
  • straight waxes e.g., without limitation, jojoba oil or mixtures with other waxes, e.g., without limitation, beeswax, carnauba, or candelilla wax
  • patient compliance may be improved by the present invention because the skin feel is further improved.
  • the dry powders of such micro or sub-micro particles may be agglomerated.
  • the particles have to be de-agglomerated in order to obtain an even distribution of the particles in the final composition. This can be accomplished by using volatile solvents which show some affinity to the halopolymer.
  • Preferred solvents include, but are not limited to, volatile silicones, linear or cyclic, having from 2 to 7 silicon atoms and from 1 to 10 alkyl groups (e.g., without limitation, hexamethyldisiloxane, dimethicones, octamethylcyclotetrasiloxane, decamethylcyclopenta-siloxane, dimethicone siloxane, octamethyltrisiloxane and /or mixtures thereof).
  • volatile silicones linear or cyclic, having from 2 to 7 silicon atoms and from 1 to 10 alkyl groups (e.g., without limitation, hexamethyldisiloxane, dimethicones, octamethylcyclotetrasiloxane, decamethylcyclopenta-siloxane, dimethicone siloxane, octamethyltrisiloxane and /or mixtures thereof).
  • Perfluorobutyl ether and methylperfluoroisobutylether are preferred solvents.
  • Other preferred solvents are C 8-9 to C] - 0 isoparaffins (e.g., without limitation, Isopar® from Exxon Corporation). The solvents may be used individually or in combination.
  • the submicro or micro particles of the perhalogenopolymers may be dispersed in a convenient liquid.
  • Micronised or submicronized perhalopolymers have been known in the art for more than a quarter of a century. However, until the present invention, they did not work as expected in the field of skin protectants and skin care because semisolid anhydrous preparations containing such particles lack cosmetic elegance. Therefore, the compliance of treatments with such preparations was unsatisfactory. Additionally, when the micronized or submicronized particles are used as a component of an emulsion, they lose a great part of their sensorial qualities (often from interactions with emulsifiers).
  • glycerol would not be soluble at 3%.
  • solubility parameters of cyclomethicones e.g., without limitation, wliite mineral oil and petrolatum are in the 5.77 to 7.33 range, whereas those of propylene glycol is 14.0 and glycerol is 16.26.
  • a difference of smaller than 2 usually indicates mutual solubility (Vaughan CD., J. Soc. Cosmet. Chem. 36, 319-333, 1985).
  • lipid-soluble molecules containing 2 or more hydroxyls including, but not limited to, dipropylene glycol, 2-ethylhexanediol, octanediol, panthenol, phytantriol, certain ceramides (6), and sphinganine.
  • Lipoinsoluble polyols e.g., without limitation, inositol or glycerol
  • the molecular weight of such components is below 1000 and the liposolubility has to be at least 0.2 %w/w.
  • examples are, without limitation, glycerolisostearate, pentaerithityl mono- and distearate (which are emulsifiers). These example may interfere with the stratum corneum lipids. More preferable examples are sphingosine and (soy-) lecithin (which contains phosphatidyl inositol).
  • Suitable halocarbon microparticles have diameters in the range of 0.1 (or smaller) to 50 micrometers, such as Algoflon HC® from Ausimont, FluoroPUREr from Shamrock Technologies, and Fluortress from DuPont. See, International Cosmetic Ingredients Dictionary and Handbook, 8th Ed 2000.
  • the diameter of micro or sub-micro particles is preferably about 100 nanometers to about 50 microns.
  • compositions of the present invention with their superior skin feel are ideal excipients for dermatological products since they adhere well to skin, and are not easily washed off. For these reasons, active ingredients, delivered by these excipients, remain in contact with the skin longer. In most cases, an increased occlusivity induces a higher moisturization of the skin, and as a consequence, an increased transdermal absorption of active ingredients. By varying the type and amount of amphiphilic bis/oligo hydroxylated lipids, the occlusive effect can be varied correspondingly.
  • the amount of polyethylene may be reduced in order to obtain a viscous liquid.
  • the nanoparticle size of the used PTFE induces practically no sedimentation.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

A composition comprises amphiphobic halo carbon particles, and amphiphilic lipids having at least 2 hydroxyl groups. This composition may be used in methods of decreasing oiliness, greasiness, stickiness and tackiness of anhydrous semisolid lipids, methods of delivering pharmaceutical active ingredients, methods of preventing or treating sunburn or ultraviolet radiation, methods or preventing or treating skin disorders and methods of delivering cosmetics.

Description

METHOD AND COMPOSITION FOR IMPROVING SENSORY CHARACTERISTICS OF SEMISOLID PREDOMINANTLY ANHYDROUS
Background of the Invention The present invention is directed to a method of improving the adhesion of semisolid predominantly anhydrous lipids to certain substrates. This method decreases oiliness, greasiness, stickiness, and tackiness and improves the adhesion of the lipids to a substrate. These lipids may be applied to surfaces, including, but not limited to hair, leather, paper, skins textiles and wood, where an impermeableness against water, but not water vapor, is desirable.
The principal function of the skin is to keep water in and exogenous substances out. This is accomplished by a highly ordered barrier, located in the stratum corneum, the skin's outermost layer. The stratum corneum composed of comeocytes (or horny cells) embedded in lipid lamellae, composed mainly of ceramides, cholesterol and free fatty acids. The horny layer is incessantly exposed to an oxidative environment (including, but not limited to UN radiation, ozone, aerobic microorganisms, and metallic microparticles). However, the homy layer is defended by antioxidant tocopherols, which are contained in the sebum that is continually secreted by the sebaceous glands, and ascorbic acid, which is secreted by the eccrine glands.
By frequent washing, especially of the hands, sebum and eccrine fluid is withdrawn leaving the skin exposed to increased oxidative stress, which damages a linoleic acid containing ceramide. This may result in a decreased barrier function and therefore an increased transepidermal water loss, which may ultimately cause dry skin.
Anhydrous lipid-rich preparations such as petrolatum or lanolin, which are not easily washed-off, seem appealing but they are not used since they are lacking in cosmetic elegance. Therefore, less greasy skin creams are often applied. Such skin creams are often emulsions containing emulsifiers which are known to be potential skin irritants. Additionally, such emulsions contain a water phase which has to be preserved in order to avoid microbial contamination. Perfumes are often included in these formulations. Both the preservatives and perfumes frequently cause allergic reactions. In the formulation of dermatological vehicles, therapeutic efficacy is an important goal. Skin penetration of active ingredients are frequently more enhanced by anhydrous semisolid excipients than by creams (which are semisolid emulsions). Anhydrous semi-solid excipients based on hydrocarbons moisturize the skin by occlusion and enhance overall skin quality more readily than creams.
Furthermore, anhydrous semi-solid hydrocarbon excipients do not degrade from bacterial lipases. In spite of these advantages, creams are very often preferred to ointments, in the art, because they are more pleasant to use and therefor better accepted by patients.
On the other hand there is a disadvantage of semisolid anhydrous ointments as moisturizers. If they are applied immediately prior to dressing, and only a short time is available for absorption, then a noteworthy excess residue of the applied product is left to be absorbed by clothes, possibly affecting the actual use and acceptability.
Prior patents provide no teaching concerning the use of combinations of amphiphobic submicro or microparticles of halocarbons and amphiphilic diols, triols or polyols as effective in improving the cosmetic elegance of semisolid lipids. An amphiphilic product includes both hydrophilic and lipophilic groups. An amphiphobic product does not include either a hydrophilic or a lipophilic group.
Other patents in this field include British Patent 1575 201 (filed Oct. 22, 1975); U.S. Patent No. 4,087,517 (1976); Japanese Patent No. 6228 3920; European Patent No. 0 598 412; and WO 02/03946 Al.
The greasier and stickier a moisturizer is, the less cosmetically acceptable it is. Increases in the lipid content of a moisturizer often increases the greasiness and stickiness of the moisturizer. For this reason, it is desirable to suppress the greasiness and stickiness of lipid-rich preparations (e.g. petrolatum or other formulations consisting mainly of hydrocarbons). As was recognized by Kligman twenty years ago, "A boon to all sufferers from dry skin would be a product with the efficacy of petrolatum and the hedonic-aesthetic properties of a light oil in water cream." ( Kligman A.M. and Leydeii J.J.: Safety and Efficacy of Topical Drugs and Cosmetics, New York Grune & Stratton, 1982, p. 236.) Water is the plasticiser of the skin. Lipid content is of major importance to the plasticity of the skin because the presence of lipids decreases transepidermal water loss and consequently increases moisture content of the stratum corneum. Therefore, lipid-rich formulations are effective in the treatment of dry skin.
Summary of the Invention
The present invention is quite unexpected. The sensory characteristics, the aesthetic appeal and thereby the user acceptance of anhydrous semisolid lipids can be greatly improved with the addition of a combination of amphiphobic micro or sub-micro particles of polymerized perhalogenoalkenes and at least one amphiphilic lipid containing at least two hydroxyl groups.
Examples of such semisolid lipids are mainly complex mixtures of hydrocarbons (e.g., without limitation, petrolatum) or combinations of liquid hydrocarbons (e.g., without limitation, paraffin oils or oligomers of monoolefins, e.g., without limitation, ethylene, propylene, butylene, isobutylene, and decene) with solid polymers of monoolefins, esters and combinations of liquid and /or solid esters
(e.g., without limitation, waxes), semisoft triglycerides or any combination thereof (e.g., without limitation, lanolin or wool wax).
A preferred embodiment is anhydrous lanolin, a water-free refined substance, which is a rather complex mixture of esters of alcohols (e.g., without limitation, monohydric, dihydric, sterols, and friterpenols) with straight or branched fatty acids.
The lipids, used in this invention, preferably contain minimal quantities of water. The amount depends on the chemical composition. For example, cenfrifuged raw wool wax contains 1-5 % water. At 32°C (the approximate temperature of the skin surface), water is only very slightly soluble in liquid hydrocarbons (less than
75 ppm), whereas esters (e.g., without limitation, dibutyladipat) may contain up to 100 times more water.
Lipids with high water content are less occlusive than lipids with low water content. For example, hydrocarbons, which have a low water content, excel in the treatment of dry skin by occlusion. Branched lipids (e.g., without limitation, petrolatum) are generally sticky and greasy. Additionally, bulky lipids (e.g., without limitation, anhydrous lanolin) also tend to be sticky and greasy. On the other hand, straight waxes (e.g., without limitation, jojoba oil or mixtures with other waxes, e.g., without limitation, beeswax, carnauba, or candelilla wax) are much less greasy and sticky. However, patient compliance may be improved by the present invention because the skin feel is further improved.
The dry powders of such micro or sub-micro particles may be agglomerated. In which case, the particles have to be de-agglomerated in order to obtain an even distribution of the particles in the final composition. This can be accomplished by using volatile solvents which show some affinity to the halopolymer. Preferred solvents include, but are not limited to, volatile silicones, linear or cyclic, having from 2 to 7 silicon atoms and from 1 to 10 alkyl groups (e.g., without limitation, hexamethyldisiloxane, dimethicones, octamethylcyclotetrasiloxane, decamethylcyclopenta-siloxane, dimethicone siloxane, octamethyltrisiloxane and /or mixtures thereof). Perfluorobutyl ether and methylperfluoroisobutylether (e.g., without limitation, HFE-7100 and HFE- 7200 from 3M Chemicals), which show a high affinity to the halogenopolymers, are preferred solvents. Other preferred solvents are C8-9 to C] - 0 isoparaffins (e.g., without limitation, Isopar® from Exxon Corporation). The solvents may be used individually or in combination.
The submicro or micro particles of the perhalogenopolymers may be dispersed in a convenient liquid. Micronised or submicronized perhalopolymers have been known in the art for more than a quarter of a century. However, until the present invention, they did not work as expected in the field of skin protectants and skin care because semisolid anhydrous preparations containing such particles lack cosmetic elegance. Therefore, the compliance of treatments with such preparations was unsatisfactory. Additionally, when the micronized or submicronized particles are used as a component of an emulsion, they lose a great part of their sensorial qualities (often from interactions with emulsifiers).
In an anhydrous semisolid lipid composition of the present invention, glycerol would not be soluble at 3%. In one embodiment, the solubility parameters of cyclomethicones, e.g., without limitation, wliite mineral oil and petrolatum are in the 5.77 to 7.33 range, whereas those of propylene glycol is 14.0 and glycerol is 16.26. A difference of smaller than 2 usually indicates mutual solubility (Vaughan CD., J. Soc. Cosmet. Chem. 36, 319-333, 1985).
Examples of suitable diols /polyols in accordance with the present invention for improving the sensory properties of semisolid embodiments are lipid-soluble molecules containing 2 or more hydroxyls, including, but not limited to, dipropylene glycol, 2-ethylhexanediol, octanediol, panthenol, phytantriol, certain ceramides (6), and sphinganine.
Lipoinsoluble polyols (e.g., without limitation, inositol or glycerol) can be made liposoluble by etherification or esterification with a suitable alcohol or acid respectively. The molecular weight of such components is below 1000 and the liposolubility has to be at least 0.2 %w/w. Examples are, without limitation, glycerolisostearate, pentaerithityl mono- and distearate (which are emulsifiers). These example may interfere with the stratum corneum lipids. More preferable examples are sphingosine and (soy-) lecithin (which contains phosphatidyl inositol).
Suitable halocarbon microparticles have diameters in the range of 0.1 (or smaller) to 50 micrometers, such as Algoflon HC® from Ausimont, FluoroPUREr from Shamrock Technologies, and Fluortress from DuPont. See, International Cosmetic Ingredients Dictionary and Handbook, 8th Ed 2000. The diameter of micro or sub-micro particles is preferably about 100 nanometers to about 50 microns.
Detailed Description of the Invention
Compositions of the present invention with their superior skin feel are ideal excipients for dermatological products since they adhere well to skin, and are not easily washed off. For these reasons, active ingredients, delivered by these excipients, remain in contact with the skin longer. In most cases, an increased occlusivity induces a higher moisturization of the skin, and as a consequence, an increased transdermal absorption of active ingredients. By varying the type and amount of amphiphilic bis/oligo hydroxylated lipids, the occlusive effect can be varied correspondingly.
Many formulations have been made in laboratory experiments to show the benefits of the various embodiments of the invention and the ingredients used. Example 1
Figure imgf000007_0001
Heat mineral oil, jojoba oil, A-C polyethylene and panthenol in a container equipped with a stirrer to 95°C. When a homogenous liquid is obtained, add polytetrafluoroethylene (PTFE) dispersed in the octamethylcyclotetrasiloxane. Cool under continuous stirring to 50 °C.
All percentages in this disclosure are weight percentages unless otherwise noted. II. Example 2
Figure imgf000007_0002
-7-
Figure imgf000008_0001
III. Example 3
Figure imgf000008_0002
IV. Example 4
Figure imgf000008_0003
Figure imgf000009_0001
Heat panalene, Hoechst wax, lanolin and EHDIOL to 115°C until a clear solution is obtained, then add the dispersed PTFE and silicone and cool while stirring to 40 °C.
In this example, the amount of polyethylene may be reduced in order to obtain a viscous liquid. The nanoparticle size of the used PTFE induces practically no sedimentation.
V. Example 5
Figure imgf000009_0002
9-
Figure imgf000010_0001
Heat the ingredients, except the PTFE and the siloxane, to 80° until a solution is obtained. Then cool to 60°C and add the remaining components. Because hexamethylsiloxane is very volatile, it is preferable to use a closed kettle equipped with a condenser.
VI. Example 6
Figure imgf000010_0002
Add PTFE dispersed in HFE-7200 together with the isoparaffin to the molten other ingredients. It is understood that while the invention has been described in conjunction with the detailed description thereof, that the foregoing description is intended to illustrate and not limit the scope of the invention, which is defined by the scope of the appended claims. Other aspects, advantages, and modifications are evident from a review of the following claims.

Claims

What is claimed:
1. A method of decreasing oiliness, greasiness, stickiness and tackiness of anhydrous semisolid lipids comprising combining amphiphobic halocarbon particles and at least one amphiphilic lipid having at least 2 hydroxyl groups.
2. The method of claim 1 wherein the amphiphobic halocarbon particles are selected from the group consisting of polytetrafluorethylene, polychlorotrifluoroethylene, polyhexafluoropropylene, polyvinylidine fluoride, polyvinylfluoride, copolymer mixtures of tetrafluorethylene and ethylene, and mixtures of tetrafluoroethylene, propylene and fluorinated copolymers of ethylene propylene.
3. The method of claim 2 wherein the amphiphobic halocarbon particles are present at about 0.2% to about 20%.
4. The method of claim 2 wherein the amphiphobic halocarbon particles are present at about 0.5% to about 5%.
5. The method of claim 2 wherein the amphiphobic halocarbon particles are present at about 1.5% to about 2.5%.
6. The method of claim 1 wherein the amphiphilic lipids are selected from the group consisting of diols, thiols and polyols.
7. The method of claim 6 wherein the amphiphilic lipids are soluble to at least 0.2 % in an anhydrous excipient and the lipids have a molecular weight of less than 1000.
8. The method of claim 1 wherein the amphiphobic halocarbon particles are in solution, the solution comprises a volatile solvent.
9. The method of claim 8 wherein the solvent has a boiling point below 250°C.
10. The method of claim 8 wherein the solvent is selected from the group consisting of hexamethyldisiloxane octamethylcyclotefrasiloxane, decamethylcyclopentasiloxane, dimethicone and octamethyltrisiloxane, dimethicone and mixtures thereof.
11. The method of claim 8 wherein the solvent is selected from the group consisting of Cι1-13 isoparaffin.
12. The method of claim 11 wherein the paraffin is present at about 0% to about 60%.
13. A method of delivering pharmaceutical active ingredients comprising combining amphiphobic halocarbon particles and at least one amphiphilic lipid having at least 2 hydroxyl groups and adding at least one pharmaceutical active ingredient to the combination.
14. A method of preventing or treating sunburn or ultraviolet radiation comprising topically applying a combination of one or more sunscreens, amphiphobic halocarbon particles and at least one amphiphilic lipid having at least 2 hydroxyl groups.
15. A method of preventing or treating skin disorders comprising topically applying amphiphobic halocarbon particles and at least one amphiphilic lipid having at least 2 hydroxyl groups.
16. The method of claim 15 wherein the skin disorder is dry skin .
17. A method of delivering cosmetics to skin comprising topically applying a combination of one or more cosmetics, amphiphobic halocarbon particles and at least one amphiphilic lipid having at least 2 hydroxyl groups.
18. A composition comprising amphiphobic halocarbon particles; and amphiphilic lipids having at least 2 hydroxyl groups.
19. The composition of claim 18 further comprising one or more pharmaceutically active ingredients.
20. The composition of claim 18 further comprising one or more sunscreens.
21. The composition of claim 18 further comprising one or more cosmetic ingredients.
22. The composition of claim 18 wherein the amphiphobic halocarbon particles are selected from the group consisting of polytetrafluorethylene (PTFE), polychlorotrifluoroethylene, polyhexafluoropropylene, polyvinylidine fluoride, polyvinylfluoride, copolymer mixtures of tetrafluorethylene and ethylene, and mixtures of tetrafluoroethylene, propylene and fluorinated copolymers of ethylene propylene.
23. The composition of claim 22 wherein the amphiphobic halocarbon particles are present at about 0.2% to about 20%.
24. The composition of claim 22 wherein the amphiphobic halocarbon particles are present at about 0.5% to about 5%.
25. The composition of claim 22 wherein the amphiphobic halocarbon particles are present at about 1.5% to about 2.5%.
26. The composition of claim 18 wherein the amphiphilic lipids are selected from the group consisting of diols, thiols and polyols.
27. The composition of claim 26 wherein the amphiphilic lipids are soluble to at least 0.2 % in an anhydrous excipient and the lipids have a molecular weight of less than 1000.
28. The composition of claim 18 wherein the amphiphobic halocarbon particles are in solution, the solution comprises a volatile solvent.
29. The composition of claim 28 wherein the solvent has a boiling point below 250°C.
30. The composition of claim 28 wherein the solvent is selected from the group consisting of hexamethyldisiloxane octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dimethicone and octamethyltrisiloxane, dimethicone and mixtures thereof.
31. The composition of claim 28 wherein the solvent is selected from the group consisting of Cπ-13 isoparaffin.
32. The composition of claim 31 wherein the paraffin is present at about 0% to about 60%.
PCT/IB2003/001700 2002-06-06 2003-03-27 Method and composition for improving sensory characteristics of semisolid predominantly anhydrous Ceased WO2003103624A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2004510744A JP2005533044A (en) 2002-06-06 2003-03-27 Methods and compositions for improving the sensory properties of semi-solid, nearly anhydrous lipids
CA002487961A CA2487961A1 (en) 2002-06-06 2003-03-27 Method and composition for improving sensory characteristics of semisolid predominantly anhydrous
AU2003219445A AU2003219445A1 (en) 2002-06-06 2003-03-27 Method and composition for improving sensory characteristics of semisolid predominantly anhydrous
EP03715257A EP1519707A1 (en) 2002-06-06 2003-03-27 Method and composition for improving sensory characteristics of semisolid predominantly anhydrous lipids

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/163,523 2002-06-06
US10/163,523 US20030228335A1 (en) 2002-06-06 2002-06-06 Method for improving sensory characteristics of semisolid predominantly anhydrous lipids

Publications (2)

Publication Number Publication Date
WO2003103624A1 true WO2003103624A1 (en) 2003-12-18
WO2003103624B1 WO2003103624B1 (en) 2004-02-26

Family

ID=29709990

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2003/001700 Ceased WO2003103624A1 (en) 2002-06-06 2003-03-27 Method and composition for improving sensory characteristics of semisolid predominantly anhydrous

Country Status (8)

Country Link
US (1) US20030228335A1 (en)
EP (1) EP1519707A1 (en)
JP (1) JP2005533044A (en)
CN (1) CN1665476A (en)
AU (1) AU2003219445A1 (en)
CA (1) CA2487961A1 (en)
RU (1) RU2004139107A (en)
WO (1) WO2003103624A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006106398A1 (en) * 2005-04-05 2006-10-12 Suess Hans R Method for improving sensory characteristics of semisolid predominantly anhydrous lipids
EP1764076A3 (en) * 2005-09-16 2007-07-25 Betafarma S.p.A. Hygienic and cosmetic compositions for treating atopical dermatitIs

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8206728B2 (en) 2004-11-18 2012-06-26 L'oréal Sunscreen compositions containing fluorinated alkyl ethers
JP4546228B2 (en) * 2004-12-02 2010-09-15 株式会社資生堂 Oily skin external composition for promoting percutaneous absorption
JP2010501600A (en) * 2006-08-28 2010-01-21 スース,ハンス,アール. Anhydrous, urea-containing skin or cosmetic preparations
JP7559497B2 (en) * 2020-10-26 2024-10-02 Agc株式会社 Dispersion and method for producing laminate

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575201A (en) * 1977-01-14 1980-09-17 Scott H Method of lubricating or softening the skin
EP0598412A2 (en) * 1992-11-19 1994-05-25 MEDICON GESELLSCHAFT FÜR UNTERNEHMENSBERATUNG IM BEREICH MEDIZIN UND GESUNDHEITSWESEN mbH Skinprotection composition
WO1997030682A1 (en) * 1996-02-22 1997-08-28 L'oreal Cosmetic fixative composition providing shine
EP0997134A1 (en) * 1998-10-06 2000-05-03 L'oreal Use of a specific particulate phase in a cosmetic composition
WO2001003653A1 (en) * 1999-07-08 2001-01-18 L'oreal Mascara comprising a polyurethane and fibres
US6309655B1 (en) * 1999-04-30 2001-10-30 The Andrew Jergens Company Self-indicating cosmetic composition
WO2001089466A1 (en) * 2000-05-23 2001-11-29 The Procter & Gamble Company Skin care moisturizing and sunscreen compositions comprising organic particulate material
WO2002003946A1 (en) * 2000-07-12 2002-01-17 L'oreal Composition comprising a modified beeswax and a volatile silicone, cosmetic use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019604A (en) * 1989-04-26 1991-05-28 Lemole Gerald M Protective gel composition
US20030147830A1 (en) * 2002-01-30 2003-08-07 The Procter & Gamble Company Topical skin and/or hair compositions containing protein

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575201A (en) * 1977-01-14 1980-09-17 Scott H Method of lubricating or softening the skin
EP0598412A2 (en) * 1992-11-19 1994-05-25 MEDICON GESELLSCHAFT FÜR UNTERNEHMENSBERATUNG IM BEREICH MEDIZIN UND GESUNDHEITSWESEN mbH Skinprotection composition
WO1997030682A1 (en) * 1996-02-22 1997-08-28 L'oreal Cosmetic fixative composition providing shine
EP0997134A1 (en) * 1998-10-06 2000-05-03 L'oreal Use of a specific particulate phase in a cosmetic composition
US6309655B1 (en) * 1999-04-30 2001-10-30 The Andrew Jergens Company Self-indicating cosmetic composition
WO2001003653A1 (en) * 1999-07-08 2001-01-18 L'oreal Mascara comprising a polyurethane and fibres
WO2001089466A1 (en) * 2000-05-23 2001-11-29 The Procter & Gamble Company Skin care moisturizing and sunscreen compositions comprising organic particulate material
WO2002003946A1 (en) * 2000-07-12 2002-01-17 L'oreal Composition comprising a modified beeswax and a volatile silicone, cosmetic use thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006106398A1 (en) * 2005-04-05 2006-10-12 Suess Hans R Method for improving sensory characteristics of semisolid predominantly anhydrous lipids
EP1764076A3 (en) * 2005-09-16 2007-07-25 Betafarma S.p.A. Hygienic and cosmetic compositions for treating atopical dermatitIs

Also Published As

Publication number Publication date
CA2487961A1 (en) 2003-12-18
CN1665476A (en) 2005-09-07
RU2004139107A (en) 2005-06-27
AU2003219445A1 (en) 2003-12-22
JP2005533044A (en) 2005-11-04
EP1519707A1 (en) 2005-04-06
US20030228335A1 (en) 2003-12-11
WO2003103624B1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
JP7079827B2 (en) External skin composition containing an oily moisturizer
JP3993505B2 (en) Water-in-oil emulsified cosmetic
EP1097744B1 (en) Polar solvent-in-oil emulsions and multiple emulsions
FR2794998A1 (en) ORGANOGELS AND THEIR USES, ESPECIALLY COSMETICS
US20030228335A1 (en) Method for improving sensory characteristics of semisolid predominantly anhydrous lipids
KR102662132B1 (en) Anhydrous Silky Cosmetics
JPH07330544A (en) Cosmetics
CA2217039A1 (en) Use of a liquid, non-ionic, amphiphilic lipid-based nanoemulsion for keratonic fibres
JPH11263721A (en) Oil-in-water type gommage (peeling) cosmetic
JP5770490B2 (en) Oil-in-water emulsified cosmetic
US20050196365A1 (en) Method for improving sensory characteristics of semisolid predominantly anhydrous lipids
US9526682B2 (en) Fine O/W emulsion
JP7828723B2 (en) Water-in-oil emulsion cosmetic
JP3778584B2 (en) Cosmetics
JPH04312512A (en) Water-in-oil type emulsion cosmetic
EP1616554B1 (en) Fine O/W-emulsion and its use in cosmetic fields
US7875263B1 (en) Polymeric structured gels
FR2843541A1 (en) TRANSPARENT CLEANSING COMPOSITION
JP3130969B2 (en) Skin cosmetics
JP7086719B2 (en) Skin cosmetics
JPH05139932A (en) Hair cosmetics
JP3200242B2 (en) Oily cosmetics
JP4400215B2 (en) Cosmetics and hair cosmetics containing novel polymeric surfactants
JP2000007547A (en) Cosmetic
JP2004210662A (en) Emulsified cosmetic

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
B Later publication of amended claims

Effective date: 20031125

WWE Wipo information: entry into national phase

Ref document number: 2487961

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004510744

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 20038151502

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 00004/KOLNP/2005

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2003715257

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2004139107

Country of ref document: RU

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2003715257

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2003715257

Country of ref document: EP